Join Us | Contact Us | Sitemap | Korean

      About Us | Report | Custom Research | Support


Login

Category

Telecom/Wireless

Electronic

Digital Devices/Media/Broadcasting

Information Technology

Energy

Life Science

Chemical/Advanced Materials

Automotive

Environment

Consumer Goods

Marketing/Advertising

Finance

Construction

Transportation

Consumer Survey

Defence/Aerospace

Food/Beverage

Heavy Industry

Education

Industrial Machinery

International Trades

Sports/Leisure

Marine/Ship Building

Fashion

Government/Policy

Industrial Arts/Jewellery

Company Profiles

ETC

 
Location : HOME > Report > Life Science > Diagnostics
The Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles)
Publisher Kalorama Information
Date 2008-11
Quantity 250 pages
Type Report
Price

Print
TABLE OF CONTENTS

CHAPTER ONE: EXECUTIVE SUMMARY

  • Industry at a Glance
  • Scope and Methodology
  • Size and Growth of the Market
  • Key Issues and Trends Affecting the Market
  • Leading Market Participants
CHAPTER TWO: INDUSTRY OVERVIEW
  • Clinical Laboratory Description
  • Testing and Services
  • Routine Testing
  • Blood Cell Coun
  • Cholesterol Level Testing
  • HIV Testing
  • Anti-HIV-1 Oral Specimen Collection Device
  • Anti-HIV-1 Testing Service
  • Nucleic Acid Testing
  • Human Immunodeficiency Virus Type 1 (Anti-HIV-1 Assay)
  • Human Immunodeficiency Virus Types 1 & 2 (Anti-HIV-1/2 Assay)
  • Pap Testing
  • Pregnancy Testing
  • Substance Abuse Testing
  • Urinalysis
  • Specialty Testing
  • Endocrinology
  • Esoteric Testing
  • Genetics
  • Immunology and Molecular Microbiology
  • Oncology
  • Serology
  • Toxicology
  • Industry Structure
  • Hospital-based Laboratories
  • Physician-office Laboratories
  • Independent Clinical Laboratories
  • Incidence of Diseases
  • Demographics
  • Population Over Age 65
  • Life Expectancy
  • Regulatory Overview
  • Certificate of Waiver
  • Certificate of Provider-Performed Microscopy Procedures (PPMP)
  • Certificate of Compliance and Certificate of Accreditation States Exempt from Federal Clinical Laboratory Improvements Amendments (CLIA) of 1988
  • Insurance and Reimbursement
  • Laboratory Service Payer Types
  • Commercial Insurance Providers
  • New Developments
  • International Markets and Trends
CHAPTER THREE: LEADING MARKET PARTICIPANTS
  • Summary

  • Quest Diagnostics, Inc.

  • Company Overview
  • Performance Review
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Growth Strategy
  • Business Locations

  • Laboratory Corporation of America

  • Company Overview
  • Performance Review
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Growth Strategy
  • Locations

  • Genzyme Corporation

  • Company Overview
  • Performance Review
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Growth Strategy
  • Locations

  • DaVita

  • Company Overview
  • Performance Review
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Growth Strategy
  • Locations

  • Clarient, Inc.

  • Company Overview
  • Performance Review
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Growth Strategy
  • Locations
  • Spectra Laboratories

  • Company Overview
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Growth Strategy
  • Locations

  • BIO-REFERENCE LABORATORIES

  • Company Overview
  • Performance Review
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Growth Strategy
  • Locations

CHAPTER FOUR: MARKET TRENDS AND SUMMARY

  • Market Overview
  • Market Analysis by Laboratory Type
  • Market Analysis by Test Type
  • Competitive Analysis

CHAPTER FIVE: LIST OF MAJOR COMPANIES AND ORGANIZATIONS

LIST OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

  • Figure 1-1: U.S. Clinical Laboratory Market Analysis: 2005-2012

CHAPTER TWO: INDUSTRY OVERVIEW

  • Table 2-1: Laboratory Reference Parameters for CBC
  • Table 2-2: High Cholesterol Risk Categories
  • Table 2-3: HIV Testing Products/Services Approved by the FDA
  • Table 2-4: HCG Levels in Pregnant Women by Days Past Ovulation
  • Table 2-5: Substance Detection Periods by Test Method
  • Figure 2-1: Growth in Clinical Laboratories, 1997-2007
  • Table 2-6: U.S. Registered Hospitals by Type, 2006
  • Table 2-7: Leading For-Profit U.S. Hospital Chains, 2006
  • Table 2-8: Physicians in the US by Specialty, 1970-2000
  • Table 2-9: Leading U.S. Independent Laboratory Groups, 2007
  • Table 2-10: U.S. Prevalence of Selected Medical Conditions
  • Figure 2-2: U.S. Prevalence of Selected Medical Conditions
  • Table 2-11: The U.S. Population, 1980-2020
  • Figure 2-3: The US Population, 1980-2020
  • Table 2-12: Percent U.S. Population Over Age 65 by Year
  • Figure 2-4: Estimated Population by Age Group, 2000 and 2050
  • Table 2-13: Average U.S. Life Expectancy in Years 1980, 2004 and 2006
  • Figure 2-5: Average U.S. Life Expectancy in Years 1980 and 2006
  • Table 2-14: Selected CLIA Waived Laboratory Tests
  • Table 2-15: Provider-Performed Microscopy Procedures
  • Figure 2-6: Clinical Laboratory Certificate of Accreditation Issued by Organization (non-exempt laboratories only), December 2007
  • Table 2-16: Clinical Laboratory Certificates Issued by Type (non-exempt laboratories only), December 2007
  • Figure 2-7: Clinical Laboratory Certificates Issued by Selected State (non-exempt laboratories only), December 2007
  • Figure 2-8: Clinical Laboratory Certificates Issued by Type (non-exempt laboratories only), December 2007
  • Table 2-17: CLIA Exempt States, Number of Laboratories, 2007
  • Table 2-18: Health Insurance Trends in the United States, Estimated 2007 (millions)
  • Table 2-19: Clinical Laboratory Clients and Payers by Type
  • Figure 2-9: Clinical Laboratory Clients and Payers by Type
  • Table 2-20: Leading Commercial Insurance Providers, 2007
  • Table 2-21: Quest and LabCorp Service Contracts for Leading Insurance Providers

CHAPTER THREE: LEADING MARKET PARTICIPANTS

  • Table 3-1: Corporate Details of Quest Diagnostics
  • Figure 3-1: Quest Diagnostics¡¯ Clinical Testing Sales to Third Parties, 2005-2007 ($millions)
  • Table 3-2: Corporate Details of Laboratory Corporation of America
  • Figure 3: : Laboratory Corporation of America¡¯s Sales to Third Parties, 2005-2007 ($millions)
  • Table 3-3: Corporate Details of Genzyme Corporation
  • Figure 3-3: Genzyme Corporation Genetics/Diagnostics Sales to Third Parties, 2005-2007 ($millions)
  • Table 3-4: Corporate Details of DaVita
  • Figure 3-4: DaVita¡¯s Laboratory Service Revenues, 2006 and 2007
  • Table 3-5: Corporate Details of Clarient
  • Figure 3-5: Clarient¡¯s Sales to Third Parties, 2005-2007
  • Table 3-6: Corporate Details of Fresenius Medical Care AG
  • Table 3-7: Corporate Details of Bio-Reference Laboratories
  • Figure 3-6: Bio-Reference¡¯s Sales to Third Parties, 2005-2007

CHAPTER FOUR: MARKET TRENDS AND SUMMARY

  • Table 4-1: U.S. Clinical Laboratory Market Analysis, 2005-2007
  • Table 4-2: Forecasted U.S. Clinical Laboratory Market Analysis: 2008-2012
  • Figure 4-1: U.S. Clinical Laboratory Market Analysis: 2005-2012
  • Table 4-3: U.S. Clinical Laboratory Market Analysis by Type, 2005-2007
  • Table 4-4: Forecasted U.S. Clinical Laboratory Market Analysis by Type, 2008-2012
  • Figure 4-2: U.S. Clinical Laboratory Market Analysis by Type, 2005-2012
  • Figure 4-3: U.S. Clinical Laboratory Market Share by Type, 2007
  • Figure 4-4: U.S. Clinical Laboratory Market Share by Type, 2012
  • Table 4-5: U.S. Clinical Laboratory Market Analysis by General Test Type, 2007
  • Figure 4-5: U.S. Clinical Laboratory Market Analysis by General Test Type, 2007
  • Table 4-6: Estimated Laboratory Service Revenues and Market Share of Leading Clinical Laboratory Providers 2007
  • Figure 4-6: Estimated Laboratory Service Revenues and Market Share of Leading Clinical Laboratory Providers 2007

About Us | Privacy Polocy | Terms & Conditions | Delivery/Payment

Samwon Bldg., 210-1 Nonhyun-dong, Gangnam-gu, 135-996, Seoul, Korea | LNH, Inc.
Tel : 82-2-554-0001 / Fax : 82-2-3444-5501 / E-mail : sales@landh.co.kr
Copyright ¨Ï 2008 LNH, Inc. All rights reserved.